Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

GILEAD SCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where GILEAD SCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $10.02B came in.
  • Fiscal year ended 2025-12-31: from investing, $4.79B went out.
  • Fiscal year ended 2025-12-31: from financing, $7.75B went out.
  • Fiscal year ended 2025-12-31: change in cash, $2.43B went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2025-12-31$10.02B-$4.79B-$1.92B-$4.00B-$1.79B$408.00M-$440.00M-$2.43B
2024-12-31$10.83B-$3.45B-$1.15B-$3.92B-$1.97B$422.00M-$281.00M$3.46B*$3.91B
2023-12-31$8.01B-$2.27B-$1.00B-$3.81B-$2.25B$232.00M-$279.00M$1.98B*$673.00M
2022-12-31$9.07B-$2.47B-$1.40B-$3.71B-$1.50B$0.00$309.00M-$173.00M$74.00M
2021-12-31$11.38B-$3.13B-$546.00M-$3.60B-$4.75B$0.00$169.00M-$145.00M-$659.00M
2020-12-31$8.17B-$14.62B-$1.58B-$3.45B-$2.50B$256.00M-$138.00M$8.18B*-$5.63B
2019-12-31$9.14B-$7.82B-$1.75B-$3.22B-$2.75B$209.00M-$122.00M-$6.31B
2018-12-31$8.40B$14.36B-$2.90B-$2.97B-$6.25B$289.00M-$486.00M$10.35B
2017-12-31$11.90B-$16.07B-$954.00M-$2.73B-$1.81B$234.00M-$330.00M$8.98B*-$641.00M
2016-12-31$17.05B-$11.98B-$11.00B-$2.46B-$1.98B$208.00M-$82.00M*$5.59B*-$4.62B
2015-12-31$21.25B-$12.47B-$10.00B-$1.87B-$997.00M$319.00M$434.00M*$6.24B*$2.82B
2014-12-31$12.82B-$1.82B-$5.35B$0.00-$4.78B$331.00M$482.00M$6.29B*$7.91B
2013-12-31$3.10B-$254.00M-$582.00M$0.00-$4.44B$313.00M$279.00M$1.89B*$309.00M
2012-12-31$3.19B-$11.85B-$667.00M-$1.84B$466.00M$114.00M$2.49B*-$8.08B
2011-12-31$3.64B$3.59B-$2.38B-$649.99M$4.66B$0.00*$211.74M$40.85M-$116.60M*$8.98B
2010-12-31$2.83B-$1.94B-$4.02B$0.00$0.00$0.00*$221.22M$81.62M$2.38B*-$365.08M
2009-12-31$3.08B-$2.22B-$998.50M-$305.45M$0.00$0.00*$222.73M$80.19M-$50.40M*-$186.34M
2008-12-31$2.14B-$178.82M-$1.97B$0.00$0.00*$246.13M$191.94M$56.95M*$491.22M
2007-12-31$1.67B-$1.30B-$487.54M$0.00$0.00*$243.43M$76.28M-$3.14M*$152.08M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$3.57B*-$10.35B*-$355.00M*-$1.03B*-$17.00M*$9.00M*-$350.00M*$4.09B*
2026-03-31$2.54B$1.77B-$419.00M-$1.04B-$2.77B$166.00M-$179.00M-$1.00M*$65.00M
2025-12-31$3.33B*-$1.83B*-$230.00M*-$994.00M*-$8.00M*$32.00M*-$63.00M*
2025-09-30$4.11B*-$427.00M*-$435.00M*-$1.00B*-$9.00M*$97.00M*-$137.00M*
2025-06-30$827.00M*-$2.12B*-$527.00M*-$994.00M*-$9.00M*$27.00M*-$64.00M*
2025-03-31$1.76B-$415.00M-$730.00M-$1.01B-$1.76B$252.00M-$176.00M-$2.06B
2024-12-31$2.98B*-$225.00M*-$350.00M*-$973.00M*-$7.00M*$173.00M*-$47.00M*$3.46B*
2024-09-30$4.31B*-$710.00M*-$300.00M*-$983.00M*-$112.00M*$98.00M*-$82.00M*
2024-06-30$1.32B*-$307.00M*-$100.00M*-$972.00M*-$1.85B*$5.00M*-$36.00M*$1.00M*
2024-03-31$2.22B-$2.21B-$400.00M-$990.00M$0.00$146.00M-$116.00M-$1.00M*-$1.37B
2023-12-31$2.17B*-$727.00M*-$150.00M*-$943.00M*$0.00*$26.00M*-$34.00M*$2.00M*
2023-09-30$1.75B*-$229.00M*-$300.00M*-$953.00M*-$2.25B*$83.00M*-$78.00M*$1.98B*
2023-06-30$2.34B*-$483.00M*-$150.00M*-$944.00M*$0.00*$26.00M*-$32.00M*-$1.00M*
2023-03-31$1.74B-$826.00M-$400.00M-$969.00M$0.00$97.00M-$135.00M$1.00M*-$476.00M
2022-12-31$2.57B*-$375.00M*-$792.00M*-$915.00M*$0.00*$0.00*$176.00M*-$23.00M*
2022-09-30$2.86B*-$713.00M*-$180.00M*-$929.00M*-$1.00B*$0.00$36.00M*-$45.00M*
2022-06-30$1.80B*-$308.00M*-$72.00M*-$920.00M*$0.00*$0.00$3.00M*-$14.00M*
2022-03-31$1.84B-$1.07B-$352.00M-$945.00M-$500.00M$0.00$94.00M-$91.00M-$1.04B
2021-12-31$3.21B*-$278.00M*-$49.00M*-$894.00M*-$1.00B*$0.00*$12.00M*-$11.00M*
2021-09-30$3.25B*-$234.00M*-$145.00M*-$900.00M*-$2.50B*$0.00$57.00M*-$39.00M*
2021-06-30$2.32B*-$577.00M*-$43.00M*-$894.00M*$0.00*$12.00M*-$6.00M*
2021-03-31$2.61B-$2.04B-$309.00M-$917.00M-$1.25B$88.00M-$89.00M-$1.93B
2020-12-31$1.92B*-$8.98B*$0.00*-$858.00M*$0.00*$8.00M*-$14.00M*$995.00M*
2020-09-30$2.25B*-$271.00M*-$201.00M*-$861.00M*-$2.00B*$36.00M*-$39.00M*$7.19B*
2020-06-30$2.57B*-$5.02B*-$54.00M*-$856.00M*$0.00*$35.00M*$1.00M*
2020-03-31$1.44B-$344.00M-$1.33B-$874.00M-$500.00M$177.00M-$86.00M-$1.58B
2019-12-31$2.58B*$431.00M*-$105.00M*-$801.00M*$0.00*$27.00M*-$17.00M*
2019-09-30$2.65B*-$1.84B*-$222.00M*-$804.00M*-$1.50B*$41.00M*-$30.00M*
2019-06-30$2.34B*-$6.16B*-$588.00M*-$800.00M*-$500.00M*$38.00M*-$7.00M*-$5.69B*
2019-03-31$1.58B-$244.00M-$834.00M-$817.00M-$750.00M$103.00M-$68.00M-$1.01B
2018-12-31$2.35B*$2.73B*-$962.00M*-$736.00M*$0.00*$50.00M*-$22.00M*$3.37B*
2018-09-30$2.21B*$2.02B*-$449.00M*-$742.00M*-$1.75B*$80.00M*-$40.00M*$1.33B*
2018-06-30$1.57B*$5.24B*-$450.00M*-$740.00M*$0.00*$48.00M*-$10.00M*$5.59B*
2018-03-31$2.27B$4.35B-$1.04B-$753.00M-$4.50B$111.00M-$414.00M$55.00M
2017-12-31$2.75B*-$10.02B*-$106.00M*-$682.00M*-$1.72B*$51.00M*-$189.00M*$5.99B*-$3.92B*
2017-09-30$2.69B*-$2.11B*-$153.00M*-$682.00M*-$30.00M*$64.00M*-$20.00M*$2.99B*$2.80B*
2017-06-30$3.53B*-$4.25B*-$130.00M*-$680.00M*-$30.00M*$23.00M*-$63.00M*-$1.57B*
2017-03-31$2.92B$307.00M-$565.00M-$687.00M-$30.00M$96.00M-$58.00M$2.06B
2016-12-31$3.54B*-$2.67B*-$1.00B*-$619.00M*-$730.00M*$28.00M*$5.00M*-$32.00M*-$1.58B*
2016-09-30$4.39B*-$3.92B*-$1.00B*-$623.00M*-$5.00M*$60.00M*-$75.00M*$4.44B*$3.32B*
2016-06-30$4.99B*-$3.28B*-$1.00B*-$626.00M*-$1.12B*$28.00M*-$14.00M*$1.17B*$170.00M*
2016-03-31$4.13B-$2.11B-$8.00B-$587.00M-$126.00M$92.00M$2.00M*$6.00M*-$6.54B
2015-12-31$5.79B*-$2.44B*-$3.05B*-$614.00M*-$234.00M*$38.00M*$87.00M*-$691.00M*-$1.11B*
2015-09-30$4.10B*-$4.19B*-$3.05B*-$627.00M*-$113.00M*$79.00M*$172.00M*$10.18B*$6.55B*
2015-06-30$5.66B*-$3.55B*-$900.00M*-$633.00M*-$451.00M*$84.00M*$140.00M*-$3.58B*-$3.22B*
2015-03-31$5.70B-$2.30B-$3.00B$0.00-$199.00M$118.00M$186.00M$174.00M*$608.00M
2014-12-31$3.02B*-$405.00M*-$2.00B*$0.00*-$1.92B*$56.00M*$124.00M*$4.97B*$3.82B*
2014-09-30$4.04B*-$770.00M*-$1.70B$0.00*-$421.00M*$0.00*$112.00M*$144.00M*-$3.91B*-$2.52B*
2014-06-30$4.18B*-$487.00M*-$1.20B$0.00*$54.00M*$57.00M*-$282.00M*$2.33B*
2014-03-31$1.57B-$161.00M-$450.00M$109.00M$157.00M$3.07B*$4.29B
2013-12-31$726.80M*$216.76M*-$399.74M*-$2.22B*$72.33M*$110.27M*$1.59B*$101.96M*
2013-09-30$753.10M*-$8.03M*-$100.02M*-$89.19M*$0.00*$94.33M*$79.58M*-$926.93M*-$191.44M*
2013-06-30$953.00M*-$55.48M*$0.00*-$1.79B*$0.00*$60.29M*$48.41M*$1.12B*$338.20M*
2013-03-31$672.10M-$407.26M-$82.24M$86.05M$40.75M-$243.56M*$60.28M
2012-12-31$706.01M*$50.12M*-$200.00M*-$789.00M*-$100.00M*$115.74M*$49.05M*$414.02M*$253.07M*
2012-09-30$745.37M*-$518.04M*-$205.21M*-$350.00M*$0.00*$798.96M*$148.47M*$29.52M*-$729.25M*-$74.79M*
2012-06-30$1.29B*-$634.96M*-$241.02M*-$350.00M*$0.00*-$350.00M*$69.26M*$12.13M*$384.75M*$173.56M*
2012-03-31$452.97M-$10.74B-$20.77M-$350.00M$0.00$647.89M*$132.53M$1.17B*$275.79M*-$8.43B
2011-12-31$978.11M*$4.44B*-$226.30M*$3.67B*$0.00*$53.50M*$10.59M*$15.49M*$8.97B*
2011-09-30$897.11M*-$80.32M*-$883.97M*$0.00*$0.00*$42.32M*$9.96M*-$44.51M*$3.58M*
2011-06-30$943.25M*-$469.79M*-$724.16M*$0.00*$0.00*$57.03M*$6.04M*-$710.88M*-$930.20M*
2011-03-31$820.54M-$300.38M-$548.70M$987.37M$0.00*$58.88M$14.26M*-$26.70M*$928.10M
2010-12-31$724.84M*-$407.82M*-$615.54M*$0.00*$0.00*$54.40M*$12.98M*$88.51M*-$115.11M*
2010-09-30$739.42M*-$1.39B*-$1.55B*$0.00*$22.54M*$7.95M*$1.79B*-$459.65M*
2010-06-30$699.08M*$932.97M*-$1.69B*$40.93M*$10.87M*$474.23M*$545.76M*
2010-03-31$670.57M-$1.07B-$162.52M$103.36M$49.82M$25.37M*-$336.08M
2009-12-31$955.28M*-$397.68M*-$242.00M*-$49.00K*-$200.00M*$61.80M*$20.92M*$35.25M*$248.36M*
2009-09-30$860.53M*-$426.65M*-$288.25M*-$23.00K*$0.00*$58.83M*$25.59M*-$221.47M*-$16.27M*
2009-06-30$622.92M*-$1.06B*-$238.18M*$61.15M*$12.99M*$7.75M*-$622.77M*
2009-03-31$641.33M-$328.39M-$230.06M$40.95M$20.69M$22.68M*$204.34M
2008-12-31$578.29M*$238.57M*-$753.51M*$0.00*$0.00*$69.71M*$36.22M*$67.17M*$249.88M*
2008-09-30$518.52M*-$319.08M*-$250.08M*$0.00*$0.00*$40.85M*$35.13M*$33.15M*$89.83M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31